Home › Merck dives into 'superbug' chase with Cubist
 

Keywords :   


Merck dives into 'superbug' chase with Cubist

2014-12-08 17:23:28| Biotech - Topix.net

Merck will spend $8.4 billion to buy Cubist Pharmaceuticals and push deeper into treating so-called "superbugs" that have drawn dire warnings from global health organizations. The company said Monday that the deal will give it stronger footing in hospital acute care and help it address antibiotic resistance, which the Whitehouse Station, New Jersey, drugmaker called a critical area of unmet medical need.

Tags: chase merck dives cubist

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.10Hurricane Leslie Graphics
05.10Hurricane Leslie Forecast Discussion Number 11
05.10Hurricane Leslie Wind Speed Probabilities Number 11
05.10Hurricane Leslie Public Advisory Number 11
05.10Summary for Hurricane Leslie (AT3/AL132024)
05.10Hurricane Leslie Forecast Advisory Number 11
05.10Hurricane Kirk Graphics
05.10Hurricane Kirk Forecast Discussion Number 23
More »